 | • レポートコード：QFJ1-5610 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、B細胞リンパ腫2阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・B細胞リンパ腫2阻害剤の市場動向 ・企業の競争状況、市場シェア ・B細胞リンパ腫2阻害剤の種類別市場規模と予測2016-2027（併用療法、単剤療法） ・B細胞リンパ腫2阻害剤の用途別市場規模と予測2016-2027（慢性リンパ性白血病、小リンパ球性リンパ腫、急性骨髄性白血病） ・B細胞リンパ腫2阻害剤の北米市場規模2016-2027（アメリカ、カナダ） ・B細胞リンパ腫2阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・B細胞リンパ腫2阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・B細胞リンパ腫2阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・B細胞リンパ腫2阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie Inc.、F. Hoffmann-La Roche Ltd.、Santa Cruz Biotechnology、Tocris、Biovision） ・結論 |
Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.
The symptoms of hematological malignancies are often mild or not apparent, which delays diagnosis and treatment. To overcome this challenge, many organizations such as KNOW AML group and market vendors have been organizing awareness campaigns, which educate patients about the symptoms and available diagnostic methods and treatment options. This factor has increased the sales of various therapeutics, including BCL-2 inhibitors, which is a crucial drug for treating indications such as chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and acute myeloid leukemia (AML). The awareness programs also conduct cancer screening and encourage people to become blood stem cell donors. This will provide significant growth opportunities to market vendors.
Market Analysis and Insights: Global B-cell lymphoma 2 Inhibitors Market
The global B-cell lymphoma 2 Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global B-cell lymphoma 2 Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global B-cell lymphoma 2 Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global B-cell lymphoma 2 Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global B-cell lymphoma 2 Inhibitors market.
Global B-cell lymphoma 2 Inhibitors Scope and Market Size
B-cell lymphoma 2 Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global B-cell lymphoma 2 Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Combination Therapy
Monotherapy
Segment by Application
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Cute Myeloid Leukemia
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AbbVie Inc.
F. Hoffmann-La Roche Ltd.
Santa Cruz Biotechnology
Tocris
Biovision
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Combination Therapy
1.2.3 Monotherapy
1.3 Market by Application
1.3.1 Global B-cell lymphoma 2 Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Small Lymphocytic Lymphoma
1.3.4 Cute Myeloid Leukemia
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global B-cell lymphoma 2 Inhibitors Market Perspective (2016-2027)
2.2 B-cell lymphoma 2 Inhibitors Growth Trends by Regions
2.2.1 B-cell lymphoma 2 Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 B-cell lymphoma 2 Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 B-cell lymphoma 2 Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 B-cell lymphoma 2 Inhibitors Industry Dynamic
2.3.1 B-cell lymphoma 2 Inhibitors Market Trends
2.3.2 B-cell lymphoma 2 Inhibitors Market Drivers
2.3.3 B-cell lymphoma 2 Inhibitors Market Challenges
2.3.4 B-cell lymphoma 2 Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top B-cell lymphoma 2 Inhibitors Players by Revenue
3.1.1 Global Top B-cell lymphoma 2 Inhibitors Players by Revenue (2016-2021)
3.1.2 Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global B-cell lymphoma 2 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by B-cell lymphoma 2 Inhibitors Revenue
3.4 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio
3.4.1 Global B-cell lymphoma 2 Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by B-cell lymphoma 2 Inhibitors Revenue in 2020
3.5 B-cell lymphoma 2 Inhibitors Key Players Head office and Area Served
3.6 Key Players B-cell lymphoma 2 Inhibitors Product Solution and Service
3.7 Date of Enter into B-cell lymphoma 2 Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 B-cell lymphoma 2 Inhibitors Breakdown Data by Type
4.1 Global B-cell lymphoma 2 Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Type (2022-2027)
5 B-cell lymphoma 2 Inhibitors Breakdown Data by Application
5.1 Global B-cell lymphoma 2 Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America B-cell lymphoma 2 Inhibitors Market Size (2016-2027)
6.2 North America B-cell lymphoma 2 Inhibitors Market Size by Type
6.2.1 North America B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021)
6.2.2 North America B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027)
6.2.3 North America B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2027)
6.3 North America B-cell lymphoma 2 Inhibitors Market Size by Application
6.3.1 North America B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021)
6.3.2 North America B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027)
6.3.3 North America B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2027)
6.4 North America B-cell lymphoma 2 Inhibitors Market Size by Country
6.4.1 North America B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021)
6.4.2 North America B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe B-cell lymphoma 2 Inhibitors Market Size (2016-2027)
7.2 Europe B-cell lymphoma 2 Inhibitors Market Size by Type
7.2.1 Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2027)
7.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Application
7.3.1 Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2027)
7.4 Europe B-cell lymphoma 2 Inhibitors Market Size by Country
7.4.1 Europe B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Type
8.2.1 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Application
8.3.1 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Region
8.4.1 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America B-cell lymphoma 2 Inhibitors Market Size (2016-2027)
9.2 Latin America B-cell lymphoma 2 Inhibitors Market Size by Type
9.2.1 Latin America B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2027)
9.3 Latin America B-cell lymphoma 2 Inhibitors Market Size by Application
9.3.1 Latin America B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2027)
9.4 Latin America B-cell lymphoma 2 Inhibitors Market Size by Country
9.4.1 Latin America B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type
10.2.1 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application
10.3.1 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Country
10.4.1 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. B-cell lymphoma 2 Inhibitors Introduction
11.1.4 AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021)
11.1.5 AbbVie Inc. Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Santa Cruz Biotechnology
11.3.1 Santa Cruz Biotechnology Company Details
11.3.2 Santa Cruz Biotechnology Business Overview
11.3.3 Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Introduction
11.3.4 Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021)
11.3.5 Santa Cruz Biotechnology Recent Development
11.4 Tocris
11.4.1 Tocris Company Details
11.4.2 Tocris Business Overview
11.4.3 Tocris B-cell lymphoma 2 Inhibitors Introduction
11.4.4 Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021)
11.4.5 Tocris Recent Development
11.5 Biovision
11.5.1 Biovision Company Details
11.5.2 Biovision Business Overview
11.5.3 Biovision B-cell lymphoma 2 Inhibitors Introduction
11.5.4 Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021)
11.5.5 Biovision Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global B-cell lymphoma 2 Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Combination Therapy
Table 3. Key Players of Monotherapy
Table 4. Global B-cell lymphoma 2 Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global B-cell lymphoma 2 Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global B-cell lymphoma 2 Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2016-2021)
Table 8. Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2022-2027)
Table 10. B-cell lymphoma 2 Inhibitors Market Trends
Table 11. B-cell lymphoma 2 Inhibitors Market Drivers
Table 12. B-cell lymphoma 2 Inhibitors Market Challenges
Table 13. B-cell lymphoma 2 Inhibitors Market Restraints
Table 14. Global B-cell lymphoma 2 Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global B-cell lymphoma 2 Inhibitors Market Share by Players (2016-2021)
Table 16. Global Top B-cell lymphoma 2 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-cell lymphoma 2 Inhibitors as of 2020)
Table 17. Ranking of Global Top B-cell lymphoma 2 Inhibitors Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by B-cell lymphoma 2 Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players B-cell lymphoma 2 Inhibitors Product Solution and Service
Table 21. Date of Enter into B-cell lymphoma 2 Inhibitors Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 24. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Type (2016-2021)
Table 25. Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global B-cell lymphoma 2 Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Application (2016-2021)
Table 29. Global B-cell lymphoma 2 Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 32. North America B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 34. North America B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Inc. Company Details
Table 62. AbbVie Inc. Business Overview
Table 63. AbbVie Inc. B-cell lymphoma 2 Inhibitors Product
Table 64. AbbVie Inc. Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021) & (US$ Million)
Table 65. AbbVie Inc. Recent Development
Table 66. F. Hoffmann-La Roche Ltd. Company Details
Table 67. F. Hoffmann-La Roche Ltd. Business Overview
Table 68. F. Hoffmann-La Roche Ltd. B-cell lymphoma 2 Inhibitors Product
Table 69. F. Hoffmann-La Roche Ltd. Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021) & (US$ Million)
Table 70. F. Hoffmann-La Roche Ltd. Recent Development
Table 71. Santa Cruz Biotechnology Company Details
Table 72. Santa Cruz Biotechnology Business Overview
Table 73. Santa Cruz Biotechnology B-cell lymphoma 2 Inhibitors Product
Table 74. Santa Cruz Biotechnology Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021) & (US$ Million)
Table 75. Santa Cruz Biotechnology Recent Development
Table 76. Tocris Company Details
Table 77. Tocris Business Overview
Table 78. Tocris B-cell lymphoma 2 Inhibitors Product
Table 79. Tocris Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021) & (US$ Million)
Table 80. Tocris Recent Development
Table 81. Biovision Company Details
Table 82. Biovision Business Overview
Table 83. Biovision B-cell lymphoma 2 Inhibitors Product
Table 84. Biovision Revenue in B-cell lymphoma 2 Inhibitors Business (2016-2021) & (US$ Million)
Table 85. Biovision Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global B-cell lymphoma 2 Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. Combination Therapy Features
Figure 3. Monotherapy Features
Figure 4. Global B-cell lymphoma 2 Inhibitors Market Share by Application: 2020 VS 2027
Figure 5. Chronic Lymphocytic Leukemia Case Studies
Figure 6. Small Lymphocytic Lymphoma Case Studies
Figure 7. Cute Myeloid Leukemia Case Studies
Figure 8. B-cell lymphoma 2 Inhibitors Report Years Considered
Figure 9. Global B-cell lymphoma 2 Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global B-cell lymphoma 2 Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global B-cell lymphoma 2 Inhibitors Market Share by Regions: 2020 VS 2027
Figure 12. Global B-cell lymphoma 2 Inhibitors Market Share by Regions (2022-2027)
Figure 13. Global B-cell lymphoma 2 Inhibitors Market Share by Players in 2020
Figure 14. Global Top B-cell lymphoma 2 Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in B-cell lymphoma 2 Inhibitors as of 2020
Figure 15. The Top 10 and 5 Players Market Share by B-cell lymphoma 2 Inhibitors Revenue in 2020
Figure 16. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Type (2016-2021)
Figure 17. Global B-cell lymphoma 2 Inhibitors Revenue Market Share by Type (2022-2027)
Figure 18. North America B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America B-cell lymphoma 2 Inhibitors Market Share by Type (2016-2027)
Figure 20. North America B-cell lymphoma 2 Inhibitors Market Share by Application (2016-2027)
Figure 21. North America B-cell lymphoma 2 Inhibitors Market Share by Country (2016-2027)
Figure 22. United States B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe B-cell lymphoma 2 Inhibitors Market Share by Type (2016-2027)
Figure 26. Europe B-cell lymphoma 2 Inhibitors Market Share by Application (2016-2027)
Figure 27. Europe B-cell lymphoma 2 Inhibitors Market Share by Country (2016-2027)
Figure 28. Germany B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Share by Type (2016-2027)
Figure 36. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Share by Application (2016-2027)
Figure 37. Asia-Pacific B-cell lymphoma 2 Inhibitors Market Share by Region (2016-2027)
Figure 38. China B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America B-cell lymphoma 2 Inhibitors Market Share by Type (2016-2027)
Figure 46. Latin America B-cell lymphoma 2 Inhibitors Market Share by Application (2016-2027)
Figure 47. Latin America B-cell lymphoma 2 Inhibitors Market Share by Country (2016-2027)
Figure 48. Mexico B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Share by Type (2016-2027)
Figure 52. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Share by Application (2016-2027)
Figure 53. Middle East & Africa B-cell lymphoma 2 Inhibitors Market Share by Country (2016-2027)
Figure 54. Turkey B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE B-cell lymphoma 2 Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. AbbVie Inc. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2016-2021)
Figure 58. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2016-2021)
Figure 59. Santa Cruz Biotechnology Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2016-2021)
Figure 60. Tocris Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2016-2021)
Figure 61. Biovision Revenue Growth Rate in B-cell lymphoma 2 Inhibitors Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
B細胞リンパ腫2阻害剤のグローバル市場：規模・現状・予測2019-2025 Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild …- B細胞リンパ腫2阻害剤のグローバル市場：規模・現状・予測2019-2025 Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis.The symptoms of hematological malignancies are often mild …
- 世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Market Analysis and Insights: Global BCL-2 (B-cell lympho…
- 世界のB細胞慢性リンパ性白血病治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy…
- BCL-2（B細胞リンパ腫2）阻害剤のグローバル市場：規模・現状・予測2019-2025 Symptoms of hematologic malignancies are usually mild or inconspicuous, leading to delays in diagnosis and treatment of indications.BCL-2 (B-cell lymphoma 2) inhibitors regulates the correlation of cell apoptosis at the mitochondrial level, which has the potential to be a therapeutic target for hem…